个人中心 - 老虎社区

慢慢爬行的和小虎

我是一个好人

IP属地：北京

帖子 · 6帖子 · 6
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- 慢慢爬行的和小虎慢慢爬行的和小虎
  ·2022-03-21
  $NVDA 20220401 260.0 PUT$ send file
  1,781 评论
  点赞
  分享
  举报
- 慢慢爬行的和小虎慢慢爬行的和小虎
  ·2022-03-08
  $CBOE 20220318 115.0 CALL$ 中国
  2,284 评论
  点赞
  分享
  举报
- 慢慢爬行的和小虎慢慢爬行的和小虎
  ·2022-02-25
  $鲁证期货(01461)$中国
  4,459 评论
  点赞
  分享
  举报
- 慢慢爬行的和小虎慢慢爬行的和小虎
  ·2022-02-25
  $恒生指数2203(HSI2203)$ 期货行情稳定，期货可期
  2,379 评论
  点赞
  分享
  举报
- 慢慢爬行的和小虎慢慢爬行的和小虎
  ·2021-11-29
  focus
  非常抱歉，此主贴已删除
  2,570 评论
  4
  分享
  举报
- 慢慢爬行的和小虎慢慢爬行的和小虎
  ·2021-11-25
  不错
  《新股消息》据报泰邦生物拟明年赴港上市集资最多10亿美元
  外电引述消息报道，今年4月从美国纳斯达克退市的泰邦生物，考虑明年赴港上市，拟集资最多10亿美元，公司已与潜在财务顾问进行初步讨论。根据泰邦官网资料，公司成立於2002年，是中国领先的综合性血液制品和生物医药企业，核心业务包括血液制品和生物制品的研发、生产和销售。(jl/t)~阿思达克财经新闻网址: www.aastocks.com
  《新股消息》据报泰邦生物拟明年赴港上市集资最多10亿美元
  3,293 评论
  1
  分享
  举报
暂无关注

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4088646798271350","uuid":"4088646798271350","gmtCreate":1625543735085,"gmtModify":1642408892790,"name":"慢慢爬行的和小虎","pinyin":"mmpxdhxhmanmanpaxingdehexiaohu","introduction":"","introductionEn":null,"signature":"我是一个好人","avatar":"https://static.tigerbbs.com/2dab44b8fced62ab1a015469a98e85cc","hat":"https://static.tigerbbs.com/d30fc324d24ff33075e053005564f0df","hatId":"1640331541884_head_frame","hatName":"goods_111_name","vip":1,"status":2,"fanSize":0,"headSize":13,"tweetSize":6,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":2,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":2,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.08.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"北京","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":1,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":637906386,"gmtCreate":1647845374247,"gmtModify":1647845374247,"author":{"id":"4088646798271350","authorId":"4088646798271350","name":"慢慢爬行的和小虎","avatar":"https://static.tigerbbs.com/2dab44b8fced62ab1a015469a98e85cc","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088646798271350","authorIdStr":"4088646798271350"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/OPT/NVDA 20220401 260.0 PUT\">$NVDA 20220401 260.0 PUT$ &nbsp;</a>send file","listText":"<a href=\"https://laohu8.com/OPT/NVDA 20220401 260.0 PUT\">$NVDA 20220401 260.0 PUT$ &nbsp;</a>send file","text":"$NVDA 20220401 260.0 PUT$ send file","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/637906386","isVote":1,"tweetType":1,"viewCount":1781,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":635096138,"gmtCreate":1646732369764,"gmtModify":1646732369764,"author":{"id":"4088646798271350","authorId":"4088646798271350","name":"慢慢爬行的和小虎","avatar":"https://static.tigerbbs.com/2dab44b8fced62ab1a015469a98e85cc","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088646798271350","authorIdStr":"4088646798271350"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/OPT/CBOE 20220318 115.0 CALL\">$CBOE 20220318 115.0 CALL$ &nbsp;</a>中国","listText":"<a href=\"https://laohu8.com/OPT/CBOE 20220318 115.0 CALL\">$CBOE 20220318 115.0 CALL$ &nbsp;</a>中国","text":"$CBOE 20220318 115.0 CALL$ 中国","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/635096138","isVote":1,"tweetType":1,"viewCount":2284,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":636616904,"gmtCreate":1645791437575,"gmtModify":1645791437575,"author":{"id":"4088646798271350","authorId":"4088646798271350","name":"慢慢爬行的和小虎","avatar":"https://static.tigerbbs.com/2dab44b8fced62ab1a015469a98e85cc","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088646798271350","authorIdStr":"4088646798271350"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01461\">$鲁证期货(01461)$</a>中国","listText":"<a href=\"https://laohu8.com/S/01461\">$鲁证期货(01461)$</a>中国","text":"$鲁证期货(01461)$中国","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/636616904","isVote":1,"tweetType":1,"viewCount":4459,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":636618131,"gmtCreate":1645791288326,"gmtModify":1645791288326,"author":{"id":"4088646798271350","authorId":"4088646798271350","name":"慢慢爬行的和小虎","avatar":"https://static.tigerbbs.com/2dab44b8fced62ab1a015469a98e85cc","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088646798271350","authorIdStr":"4088646798271350"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/FUT/HSI2203\">$恒生指数2203(HSI2203)$ &nbsp;</a>期货行情稳定，期货可期","listText":"<a href=\"https://laohu8.com/FUT/HSI2203\">$恒生指数2203(HSI2203)$ &nbsp;</a>期货行情稳定，期货可期","text":"$恒生指数2203(HSI2203)$ 期货行情稳定，期货可期","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/636618131","isVote":1,"tweetType":1,"viewCount":2379,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600296724,"gmtCreate":1638154129758,"gmtModify":1638154129758,"author":{"id":"4088646798271350","authorId":"4088646798271350","name":"慢慢爬行的和小虎","avatar":"https://static.tigerbbs.com/2dab44b8fced62ab1a015469a98e85cc","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088646798271350","authorIdStr":"4088646798271350"},"themes":[],"htmlText":"focus","listText":"focus","text":"focus","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600296724","repostId":"1112314828","repostType":4,"isVote":1,"tweetType":1,"viewCount":2570,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874737452,"gmtCreate":1637822446832,"gmtModify":1637822446832,"author":{"id":"4088646798271350","authorId":"4088646798271350","name":"慢慢爬行的和小虎","avatar":"https://static.tigerbbs.com/2dab44b8fced62ab1a015469a98e85cc","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088646798271350","authorIdStr":"4088646798271350"},"themes":[],"htmlText":"不错","listText":"不错","text":"不错","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874737452","repostId":"2186367660","repostType":4,"repost":{"id":"2186367660","kind":"news","pubTimestamp":1637820749,"share":"https://www.laohu8.com/m/news/2186367660?lang=&edition=full","pubTime":"2021-11-25 14:12","market":"us","language":"zh","title":"《新股消息》据报泰邦生物拟明年赴港上市 集资最多10亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2186367660","media":"AAFN","summary":"外电引述消息报道，今年4月从美国纳斯达克退市的泰邦生物，考虑明年赴港上市，拟集资最多10亿美元，公司已与潜在财务顾问进行初步讨论。根据泰邦官网资料，公司成立於2002年，是中国领先的综合性血液制品和生物医药企业，核心业务包括血液制品和生物制品的研发、生产和销售。(jl/t)~阿思达克财经新闻网址: www.aastocks.com","content":"<html><body><p>外电引述消息报道，今年4月从美国纳斯达克退市的<a href=\"https://laohu8.com/S/CBPO\">泰邦生物</a>，考虑明年赴港上市，拟集资最多10亿美元，公司已与潜在财务顾问进行初步讨论。根据泰邦官网资料，公司成立於2002年，是中国领先的综合性血液制品和生物医药企业，核心业务包括血液制品和生物制品的研发、生产和销售。(jl/t)~阿思达克财经新闻网址: www.aastocks.com</p></body></html>","source":"aastocks","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>《新股消息》据报泰邦生物拟明年赴港上市 集资最多10亿美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n《新股消息》据报泰邦生物拟明年赴港上市 集资最多10亿美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-25 14:12 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1145417&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0><strong>AAFN</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>外电引述消息报道，今年4月从美国纳斯达克退市的泰邦生物，考虑明年赴港上市，拟集资最多10亿美元，公司已与潜在财务顾问进行初步讨论。根据泰邦官网资料，公司成立於2002年，是中国领先的综合性血液制品和生物医药企业，核心业务包括血液制品和生物制品的研发、生产和销售。(jl/t)~阿思达克财经新闻网址: www.aastocks.com</p>\n\n<a href=\"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1145417&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","relate_stocks":{"00388":"香港交易所"},"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1145417&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","is_english":false,"share_image_url":"https://static.laohu8.com/51f6b9126f36f92bbf92982596066e5a","article_id":"2186367660","content_text":"外电引述消息报道，今年4月从美国纳斯达克退市的泰邦生物，考虑明年赴港上市，拟集资最多10亿美元，公司已与潜在财务顾问进行初步讨论。根据泰邦官网资料，公司成立於2002年，是中国领先的综合性血液制品和生物医药企业，核心业务包括血液制品和生物制品的研发、生产和销售。(jl/t)~阿思达克财经新闻网址: www.aastocks.com","news_type":1,"symbols_score_info":{"00388":0.9,"CBPO":1}},"isVote":1,"tweetType":1,"viewCount":3293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"following","isTTM":false}